Q&A: Will New EU Regulations Disproportionately Increase Business Burdens?
Executive Summary
The EU's new Medical Device and IVD Regulations overhaul the regulatory regime to improve product quality, safety and reliability. Here, Medtech Insight talks to attorney Maliha Carey about the implications for operating businesses in the new environment.
You may also be interested in...
EU Court Ruling Throws Confusion On Need For Notified Body Unannounced Inspections
The European Court of Justice judgment on the TÜV Rheinland notified-body liability case raises more questions than answers. In particular, there is uncertainty over its impact on the need for notified bodies to perform unannounced audits.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.